CLASS III Drug recall · Reported 11 Jan 2017 · FDA Enforcement Report

Temazepam Capsules USP, 7.5 mg recalled by Vintage Pharmaceuticals LLC

Vintage Pharmaceuticals LLC is recalling Temazepam Capsules USP, 7.5 mg, distributed nationwide in the US. The recall was initiated on 22 Dec 2016 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesT248H15A, Exp. 08/17
Quantity recalled1200 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0326-2017
FDA event ID
76087
Recalling firm
Vintage Pharmaceuticals LLC, Huntsville, AL
Classification
Class III
Status
Terminated
Recall initiated
22 Dec 2016
FDA classified
3 Jan 2017
Reported
11 Jan 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

22 Dec 2016Recall initiated by company
3 Jan 2017Classified by FDA+12 days
11 Jan 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Stability Specifications

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

TEMAZEPAM CAPSULES USP, 7.5 mg, 100 count bottles, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-5891-21

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Failed Stability Specifications

Which lots are affected?

T248H15A, Exp. 08/17

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Vintage Pharmaceuticals LLC

All 5

Other Temazepam recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IITemazepam, Capsule, 7.5 mg recalled by Aidapak ServicesAidapak ServicesLabeling Errors4 states